Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2357-2021Class II

CombiDiagnost R90 Software Version R1.0 and R1.1

Philips Medical Systems DMC GmbH / initiated 2020-07-22 / Open, Classified / root cause: software

Philips Medical Systems Gmbh, DMC began a recall of CombiDiagnost R90 Software Version R1.0 and R1.1 on . FDA classified it as Class II and gives the reason as "Philips has become aware of a software issue, where the kV and mA values are not locked immediately but change when the collimator shutter position is changed directly after the Lock-In command. This software issue...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-2357-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Philips Medical Systems DMC GmbH
Product
CombiDiagnost R90 Software Version R1.0 and R1.1
Product code
JAA System, X-Ray, Fluoroscopic, Image-Intensified
Reason for recall
Philips has become aware of a software issue, where the kV and mA values are not locked immediately but change when the collimator shutter position is changed directly after the Lock-In command. This software issue leads to an over or under exposed image.
Root cause tag
software
FDA root cause
Radiation Control for Health and Safety Act
Action
Philips sent customers an Electronic Product Radiation Correction letter dated July 14, 2021. The letter identified the affected product, problem and actions to be taken. Philips plans to correct the defect at no cost to customers by implementing a field correction involving the installation of a software update. For questions contact the Customer Care Solutions Center 1-800-722-9377 and reference FCO70900051.
Quantity in commerce
322 systems; 66 in US
Distribution
US Nationwide Distribution
Product codes and lots
Model 706100

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2357-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2357-2021Class IIOngoingFDA Mandated